These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32896197)

  • 1. The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?
    Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Seilicovich A; Candolfi M
    Expert Opin Ther Targets; 2020 Nov; 24(11):1121-1133. PubMed ID: 32896197
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
    Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Abt A; Orrillo SJ; Lastra Y; De Simone E; Boutillon F; Goffin V; Seilicovich A; Pisera DA; Ferraris MJ; Candolfi M
    Sci Rep; 2019 Dec; 9(1):19578. PubMed ID: 31862900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.
    Alkharusi A; Yu S; Landázuri N; Zadjali F; Davodi B; Nyström T; Gräslund T; Rahbar A; Norstedt G
    Oncotarget; 2016 Nov; 7(48):79572-79583. PubMed ID: 27788487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.
    López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
    Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications.
    Goffin V; Touraine P
    Expert Opin Ther Targets; 2015; 19(9):1229-44. PubMed ID: 26063597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
    Standing D; Dandawate P; Anant S
    Front Endocrinol (Lausanne); 2022; 13():1112987. PubMed ID: 36714582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
    Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin (PRL) and prolactin receptor (PRLR) genes and their role in poultry production traits.
    Wilkanowska A; Mazurowski A; Mroczkowski S; Kokoszyński D
    Folia Biol (Krakow); 2014; 62(1):1-8. PubMed ID: 24745142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
    Langan EA; Ramot Y; Hanning A; Poeggeler B; Bíró T; Gaspar E; Funk W; Griffiths CE; Paus R
    Br J Dermatol; 2010 May; 162(5):1127-31. PubMed ID: 20302576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer.
    Damiano JS; Wasserman E
    Clin Cancer Res; 2013 Apr; 19(7):1644-50. PubMed ID: 23515410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone.
    van Agthoven J; Zhang C; Tallet E; Raynal B; Hoos S; Baron B; England P; Goffin V; Broutin I
    J Mol Biol; 2010 Nov; 404(1):112-26. PubMed ID: 20875426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of multiple first exons in murine prolactin receptor gene and the effect of prolactin on their expression in the choroid plexus.
    Tabata H; Kobayashi M; Ikeda JH; Nakao N; Saito TR; Tanaka M
    J Mol Endocrinol; 2012 Apr; 48(2):169-76. PubMed ID: 22294444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme: novel therapeutic targets.
    Muir M; Gopakumar S; Traylor J; Lee S; Rao G
    Expert Opin Ther Targets; 2020 Jul; 24(7):605-614. PubMed ID: 32394767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
    Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
    Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.
    Wen Y; Zand B; Ozpolat B; Szczepanski MJ; Lu C; Yuca E; Carroll AR; Alpay N; Bartholomeusz C; Tekedereli I; Kang Y; Rupaimoole R; Pecot CV; Dalton HJ; Hernandez A; Lokshin A; Lutgendorf SK; Liu J; Hittelman WN; Chen WY; Lopez-Berestein G; Szajnik M; Ueno NT; Coleman RL; Sood AK
    Cell Rep; 2014 Apr; 7(2):488-500. PubMed ID: 24703838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.